Antiseptics News and Research RSS Feed - Antiseptics News and Research

Antiseptics are antimicrobial substances that are applied to living tissue/skin to reduce the possibility of infection, sepsis, or putrefaction. Antiseptics are generally distinguished from antibiotics by their ability to be transported through the lymphatic system to destroy bacteria within the body, and from disinfectants, which destroy microorganisms found on non-living objects. Some antiseptics are true germicides, capable of destroying microbes (bacteriocidal), whilst others are bacteriostatic and only prevent or inhibit their growth.
New antiseptic agent holds promise for treatment of periodontitis

New antiseptic agent holds promise for treatment of periodontitis

The study, published in the journal Science and Technology of Advanced Materials, by Shinichi Arakawa and colleagues at Tokyo Medical and Dental University and Japan's National Institute of Advanced Industrial Science and Technology, evaluated the bactericidal activities of ozone nano-bubble water - also known as NBW3 - against the two main bacterial agents that cause periodontitis as well as its toxicity to human oral tissue cells. [More]
Health Canada offers tips on proper use of topical antiseptics to reduce infections

Health Canada offers tips on proper use of topical antiseptics to reduce infections

Health Canada is reminding healthcare professionals, caregivers and consumers of the safe use of topical antiseptics used to clean the skin before an operation (preoperative) or before an injection (preinjection). [More]
Helsinn, Mundipharma sign distribution and license agreement for investigational therapy

Helsinn, Mundipharma sign distribution and license agreement for investigational therapy

Helsinn and Mundipharma announce the signature of a new, exclusive license and distribution agreement, covering China, Hong Kong and Macao, for netupitant-palonosetron fixed dose combination, a Helsinn product under development for the treatment of chemotherapy-induced nausea and vomiting. [More]
Researchers identify resistance protein that allows bacteria to survive chlorhexidine

Researchers identify resistance protein that allows bacteria to survive chlorhexidine

Researchers have identified a resistance protein that allows bacteria to survive chlorhexidine, a disinfectant commonly used in wipes, cleansers and mouthwashes in hospitals. [More]

WHO, Health Care without Harm to launch Mercury-Free Healthcare by 2020

WHO and Health Care without Harm have joined forces to launch a new initiative to get mercury removed from all medical measuring devices by 2020. [More]
Weekend reading: The mystery of some innovations that are slow to be accepted; myths about the obesity crisis

Weekend reading: The mystery of some innovations that are slow to be accepted; myths about the obesity crisis

Why do some innovations spread so swiftly and others so slowly? Consider the very different trajectories of surgical anesthesia and antiseptics. ... On October 16, 1846, at Massachusetts General Hospital, Morton administered his gas through an inhaler in the mouth of a young man undergoing the excision of a tumor in his jaw. ... By February, anesthesia had been used in almost all the capitals of Europe, and by June in most regions of the world. [More]
Chemotherapy devices: an interview with Damien Salauze, head of Curie-Cancer

Chemotherapy devices: an interview with Damien Salauze, head of Curie-Cancer

Although several chemotherapy treatments are now administered by the oral route (targeted chemotherapy), most chemotherapy treatments (cytotoxics) are administered by the intravenous route. [More]
Bedside baths and bloodstream infections in children: an interview with Aaron Milstone

Bedside baths and bloodstream infections in children: an interview with Aaron Milstone

Bedside baths in the hospital are nothing new. They are typically done for patient comfort and to maintain basic personal hygiene. [More]
Neonatal TSH screening insensitive for iodine insufficiency

Neonatal TSH screening insensitive for iodine insufficiency

Measuring levels of neonatal thyroid-stimulating hormone may not be sufficiently sensitive for inferring the extent of iodine deficiency in a given population, study results suggest. [More]
Allergies and hygiene: an interview with Sally Bloomfield

Allergies and hygiene: an interview with Sally Bloomfield

Allergies occur when the body overreacts to substances in our environment, such as pollen, dust mites and so forth. What happens is that when we are exposed to these potential threats, the immune system should react, deal with it, and then shut down. [More]
‘Green’ disinfectant shows promise against hospital-acquired infections

‘Green’ disinfectant shows promise against hospital-acquired infections

Research shows that the polyhexamethylene-guanidine hydrochloride-based disinfectant Akwaton effectively destroys Bacillus subtilis spores even at low concentrations. [More]
Patients with history of skin infection more likely to develop surgical site infections

Patients with history of skin infection more likely to develop surgical site infections

Johns Hopkins scientists have engineered cells that behave like AND and OR Boolean logic gates, producing an output based on one or more unique inputs. This feat, published in the May issue of Nature Chemical Biology, could eventually help researchers create computers that use cells as tiny circuits. [More]
Surgery may be effective in difficult-to-treat epilepsy cases

Surgery may be effective in difficult-to-treat epilepsy cases

A study published this week in the journal the Lancet involved 615 patients who were suffering from refractory focal epilepsy, a type that has proved difficult to treat, even with multiple medications. [More]
New report: U.S. antiseptics and disinfectants market to reach $2.9B by 2016

New report: U.S. antiseptics and disinfectants market to reach $2.9B by 2016

In 2009, the disinfectant and antiseptic market was worth around $3.4 billion, but by 2010 had grown over 12%, to reach a value of $3.8 billion, according to a new report available from companiesandmarkets.com. [More]
Pediatric physicians present 12 research abstracts, posters at Cardiology 2011

Pediatric physicians present 12 research abstracts, posters at Cardiology 2011

Pediatric cardiology researchers and clinicians gather this week in Scottsdale, Ariz. for Cardiology 2011, the 15th Annual Update on Pediatric and Congenital Cardiovascular Disease, sponsored by The Children's Hospital of Philadelphia. Original research from more than 30 cardiac programs in the U.S. and abroad is being presented throughout the meeting. [More]
FDA issues reminder about safe use of non-sterile alcohol prep pads

FDA issues reminder about safe use of non-sterile alcohol prep pads

Following a recent recall of potentially contaminated non-sterile alcohol prep pads, the U.S. Food and Drug Administration today reminded health care professionals about the safe use of non-sterile alcohol prep pads to clean and disinfect the surface of the skin. [More]
CareFusion signs agreement with Healthpoint to market, sell surgical scrub solutions

CareFusion signs agreement with Healthpoint to market, sell surgical scrub solutions

CareFusion, a leading, global medical device company, has announced it has entered into an agreement with Healthpoint, Ltd. to market and sell innovative surgical scrub solutions, including Surgicept Waterless Surgical Hand Scrub, Triseptin Water-Aided Surgical Scrub and Triseptin Hand and Body Antiseptic. [More]
Ten prevention tips to stay safe from infection and illness during summer camp

Ten prevention tips to stay safe from infection and illness during summer camp

As summer sets in, nearly six million campers will attend summer camps in the U.S. And while summer is typically not know as cold or flu season, illnesses and injuries – some very serious – occur every year at hundreds of camps. [More]
Ansell introduces new surgical glove with AMT Antimicrobial Technology

Ansell introduces new surgical glove with AMT Antimicrobial Technology

Ansell today announced the launch of their new GAMMEX(R) Powder-Free glove with AMT Antimicrobial Technology, at the Annual Congress of the Royal Australasian College of Surgeons in Perth, Australia. [More]
NovaBay Pharmaceuticals reports net income of $2.7M for 2009 against year-ago loss

NovaBay Pharmaceuticals reports net income of $2.7M for 2009 against year-ago loss

NovaBay Pharmaceuticals, Inc., a clinical stage specialty pharmaceutical company developing first-in-class, anti-infective compounds for the treatment and prevention of antibiotic-resistant infections, today reported full-year and fourth quarter financial results for 2009. The company also highlighted recent progress of its proprietary and partnered development programs. [More]